Prophylactic Use of Postpartum Sertraline to Prevent Postpartum Depression
Prophylactic Use of Immediate Postpartum Sertraline to Prevent Postpartum Depression: A Double Blind Randomized Placebo Controlled Trial
Sponsor: The Cooper Health System
Terminated
Low recruitment, completion of funding cycle
Other terminated trials from The Cooper Health System
A NA clinical study on Depression, Postpartum, this trial is terminated or withdrawn. The trial is conducted by The Cooper Health System and has accumulated 8 data snapshots since 2014. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2023 — Jul 2024 [monthly]
Terminated NA
-
Dec 2022 — Jan 2023 [monthly]
Terminated NA
-
Jan 2021 — Dec 2022 [monthly]
Terminated NA
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
May 2017 — Jun 2018 [monthly]
Terminated NA
-
Jan 2017 — May 2017 [monthly]
Terminated NA
First recorded
Jul 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The Cooper Health System
For direct contact, visit the study record on ClinicalTrials.gov .